These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23033157)

  • 1. Bicyclic core estrogens as full antagonists: synthesis, biological evaluation and structure-activity relationships of estrogen receptor ligands based on bridged oxabicyclic core arylsulfonamides.
    Zhu M; Zhang C; Nwachukwu JC; Srinivasan S; Cavett V; Zheng Y; Carlson KE; Dong C; Katzenellenbogen JA; Nettles KW; Zhou HB
    Org Biomol Chem; 2012 Nov; 10(43):8692-700. PubMed ID: 23033157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of selective estrogen receptor modulator (SERM)-like activity through an indirect mechanism of estrogen receptor antagonism: defining the binding mode of 7-oxabicyclo[2.2.1]hept-5-ene scaffold core ligands.
    Zheng Y; Zhu M; Srinivasan S; Nwachukwu JC; Cavett V; Min J; Carlson KE; Wang P; Dong C; Katzenellenbogen JA; Nettles KW; Zhou HB
    ChemMedChem; 2012 Jun; 7(6):1094-100. PubMed ID: 22517684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor.
    Muthyala RS; Sheng S; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2003 Apr; 46(9):1589-602. PubMed ID: 12699377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and structure-activity relationships of a novel series of estrogen receptor ligands based on 7-thiabicyclo[2.2.1]hept-2-ene-7-oxide.
    Wang P; Min J; Nwachukwu JC; Cavett V; Carlson KE; Guo P; Zhu M; Zheng Y; Dong C; Katzenellenbogen JA; Nettles KW; Zhou HB
    J Med Chem; 2012 Mar; 55(5):2324-41. PubMed ID: 22283328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of estrogen receptor ligands with bridged oxabicyclic cores containing a diarylethylene motif: estrogen antagonists of unusual structure.
    Zhou HB; Comninos JS; Stossi F; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2005 Nov; 48(23):7261-74. PubMed ID: 16279785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the PROTAC degron candidates: OBHSA with different side chains as novel selective estrogen receptor degraders (SERDs).
    Li Y; Zhang S; Zhang J; Hu Z; Xiao Y; Huang J; Dong C; Huang S; Zhou HB
    Eur J Med Chem; 2019 Jun; 172():48-61. PubMed ID: 30939353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional oxabicycloheptene sulfonate targets the homologous recombination and repair programmes through estrogen receptor α antagonism.
    Wu J; Yan J; Fang P; Zhou HB; Liang K; Huang J
    Cancer Lett; 2020 Jan; 469():78-88. PubMed ID: 31629931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.
    Harrington WR; Sheng S; Barnett DH; Petz LN; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Cell Endocrinol; 2003 Aug; 206(1-2):13-22. PubMed ID: 12943986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxabicycloheptene Sulfonate Protects Against β-Amyloid-induced Toxicity by Activation of PI3K/Akt and ERK Signaling Pathways Via GPER1 in C6 Cells.
    Deng LJ; Cheng C; Wu J; Wang CH; Zhou HB; Huang J
    Neurochem Res; 2017 Aug; 42(8):2246-2256. PubMed ID: 28374135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel SERMs with a ferrocenyl entity based on the oxabicyclo[2.2.1]heptene scaffold and evaluation of their antiproliferative effects in breast cancer cells.
    Zheng Y; Wang C; Li C; Qiao J; Zhang F; Huang M; Ren W; Dong C; Huang J; Zhou HB
    Org Biomol Chem; 2012 Dec; 10(48):9689-99. PubMed ID: 23149805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the bicyclo[3.3.1]nonane system as a template for the development of new ligands for the estrogen receptor.
    Muthyala RS; Carlson KE; Katzenellenbogen JA
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4485-8. PubMed ID: 14643352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyclic amides as estrogen receptor ligands: synthesis, binding, activity and receptor interaction.
    Stauffer SR; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
    Bioorg Med Chem; 2000 Jun; 8(6):1293-316. PubMed ID: 10896109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent estrogen receptor ligands based on bisphenols with a globular hydrophobic core.
    Endo Y; Yoshimi T; Ohta K; Suzuki T; Ohta S
    J Med Chem; 2005 Jun; 48(12):3941-4. PubMed ID: 15943468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-substituted 3,4-diarylsalicylaldoximes on estrogen receptors alpha and beta.
    Minutolo F; Antonello M; Bertini S; Rapposelli S; Rossello A; Sheng S; Carlson KE; Katzenellenbogen JA; Macchia M
    Bioorg Med Chem; 2003 Apr; 11(7):1247-57. PubMed ID: 12628652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terpenoids found in the umbelliferae family act as agonists/antagonists for ER(alpha) and ERbeta: differential transcription activity between ferutinine-liganded ER(alpha) and ERbeta.
    Ikeda K; Arao Y; Otsuka H; Nomoto S; Horiguchi H; Kato S; Kayama F
    Biochem Biophys Res Commun; 2002 Feb; 291(2):354-60. PubMed ID: 11846412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel class of 7-Oxabicyclo[2.2.1]heptene sulfonamides with long alkyl chains displaying improved estrogen receptor α degradation activity.
    Hu Z; Li Y; Xie B; Ning W; Xiao Y; Huang Y; Zhao C; Huang J; Dong C; Zhou HB
    Eur J Med Chem; 2019 Nov; 182():111605. PubMed ID: 31437778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Bioactive Hybrid Compound Dual Targeting Estrogen Receptor and Histone Deacetylase for the Treatment of Breast Cancer.
    Tang C; Li C; Zhang S; Hu Z; Wu J; Dong C; Huang J; Zhou HB
    J Med Chem; 2015 Jun; 58(11):4550-72. PubMed ID: 25993269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.